candesartan has been researched along with evans blue in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
| Rydén, L; Shimizu, M; Sjöquist, PO; Wang, QD | 1 |
| Binkowski, K; Dendorfer, A; Eichler, W; Klotz, KF; Puchakayala, MR; Schumacher, J | 1 |
| Awad, AS | 1 |
4 other study(ies) available for candesartan and evans blue
| Article | Year |
|---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
Combination of a calcium antagonist, a lipid-peroxidation inhibitor, and an angiotensin AT1-receptor antagonist provides additive myocardial infarct size-limiting effect in pigs.
Topics: Anesthesia; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Antioxidants; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Coronary Disease; Drug Synergism; Drug Therapy, Combination; Evans Blue; Felodipine; Female; Hemodynamics; Indoles; Lipid Peroxidation; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Perfusion; Random Allocation; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Swine; Terphenyl Compounds; Tetrazoles | 1999 |
Effects of candesartan and enalaprilat on the organ-specific microvascular permeability during haemorrhagic shock in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Capillary Permeability; Coloring Agents; Enalaprilat; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Hemodynamics; Ileum; Kidney; Lactic Acid; Male; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Shock, Hemorrhagic; Tetrazoles | 2006 |
Role of AT1 receptors in permeability of the blood-brain barrier in diabetic hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Blood Pressure; Blood-Brain Barrier; Body Weight; Brain; Capillary Permeability; Diabetes Mellitus, Experimental; Epinephrine; Evans Blue; Glutathione; Hypertension; Indicators and Reagents; Lipid Peroxidation; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Superoxide Dismutase; Tetrazoles; Time Factors | 2006 |